Nvidia Corporation (NVDA) shares are up $1.90, or 9.63%, to $22.36 in morning trading Friday after the company reported its second quarter 2016 earnings results.
The visual computing company posted earnings of $0.34 per share on revenues of $1.15 billion, up 4.5% from $1.10 billion a year ago. Analysts were expecting EPS of $0.20 on revenues of $1.01 billion. Net income came in at $26 million, or $0.05 per share (diluted), 80% lower from $128 million, or $0.22 a share, a year earlier.
For Q3’16, NVDA issued revenue projection of $1.18 billion, compared to the consensus revenue estimate of $1.10 billion.
Nvidia shares have risen 2 percent since the beginning of the year. The Santa Clara, California-based company pays shareholders $0.39 per share annually in dividends, yielding 2.00%. Ticker has a current market cap of $12.07 billion.
—
Shares of Pixelworks, Inc. (PXLW) are lower by nearly 10% to $4.97 in morning trading on Friday after the company announced public offering of 3.25 million shares at a price of $4.75 per share with gross proceeds of $15.4 million.
Pixelworks’s trading volume jumped on the news with the issue currently trading more than 1.1 million shares, compared to the daily average volume of 411K shares.
—
Fluidigm Corporation (FLDM) reported second quarter EPS loss of ($0.53) before the opening bell Friday, compared to the consensus estimate of ($0.37). Revenues increased 3.7% from last year to $28.62 million. Analysts expected revenues of $30.43 million. For full fiscal year 2015, FLDM provided revenue guidance of $110-$115 million, compared to the consensus revenue estimate of $135.67 million.
Fluidigm stock is currently down $7.91 to $12.02 on 2.05 million shares.The stock has fallen 41% since the beginning of the year.
—
Monster Beverage Corporation (MNST) gained $5.26 to $150.13 in morning trading after it reported fiscal results for the second quarter.
In its quarterly report, the company said it earned $0.79 per share, well below the $0.91 per share analysts were expecting. Revenue rose 0.9% to $693.7 million, below views for $755.07 million.
On valuation measures, Monster Beverage Corp. shares trade at a trailing-12 P/E of 66.67, a forward P/E of 37.30 and a P/E to growth ratio of 2.07. The median Wall Street price target on the name is $151.00 with a high target of $167.00. Currently ticker boasts 9 ‘Buy’ endorsements, compared to 7 ‘Holds’ and no ‘Sell’.
MNST prints a one year return of 119.37% and a year-to-date return of around 34%.
—
Aquinox Pharmaceuticals Inc. (AQXP) is one of today’s most notable movers, up as much as 216% to $5.80. The spike comes after the clinical-stage pharmaceutical company announced positive results from secondary endpoints from phase 2 LEADERSHIP Trial with AQX-1125 in patients with bladder pain syndrome/interstitial cystitis (BPS/IC).
“Consistently positive results from multiple secondary endpoints have strengthened our confidence in further development of AQX-1125 for BPS/IC,” said in a press release Mr. David Main, President and CEO of Aquinox. “The encouraging effect of AQX-1125 observed on the primary endpoint of reduction in pain together with several statistically significant secondary endpoints, underscore the potential of AQX-1125 as a once daily, oral therapy for this debilitating disease.”
Disclaimer: This page contains affiliate links. If you choose to make a purchase after clicking a link, we may receive a commission at no additional cost to you. Thank you for your support!
Leave a Reply